Technical and clinical outcome for all, transferred and directly admitted patients
| Excluding pre-stroke mRS >1 | ||||
|---|---|---|---|---|
| Technical/clinical outcome | All patients (n=100) | Transferred patients (n=53) | Directly admitted patients (n=38) | p Value |
| Final o-TICI 2b-3 only pREset | ||||
| % (n/n vessels) | 84.4% (92/109) | 84.2% (48/57) | 82.6% (38/46) | 0.828 |
| Final o-TICI 2b–3 overall | ||||
| % (n/n vessels) | 85.3% (93/109) | 86.0% (49/57) | 82.6% (38/46) | 0.640 |
| Passages until final o-TICI overall | ||||
| Mean (n vessels; SD) | 1.91 (109; 1.31) | 1.95 (57; 1.38) | 1.91 (46; 1.30) | 0.898 |
| Intraprocedural complications | ||||
| % (n/n) | 10.0% (10/100) | 9.4% (5/53) | 13.2% (5/38) | 0.575 |
| Emboli to new or same territory | ||||
| % (n/n) | 5.0% (5/100) | 1.9% (1/53) | 10.5% (4/38) | 0.157 |
| Hemorrhage post | ||||
| Any hemorrhage, % (n/n) | 14.0% (14/100) | 13.2% (7/53) | 18.4% (7/38) | 0.497 |
| Parenchymal, % (n/n) | 6.0% (6/100) | 7.5% (4/53) | 5.3% (2/38) | 1.000 |
| Subarachnoid, % (n/n) | 7.0% (7/100) | 3.8% (2/53) | 13.2% (5/38) | 0.124 |
| Subdural, % (n/n) | 2.0% (2/100) | 3.8% (2/53) | 0.0% (0/38) | 0.508 |
| Symptomatic, % (n/n) | 2.0% (2/100) | 1.9% (1/53) | 2.6% (1/38) | 1.000 |
| NIHSS at 24–72 hours | ||||
| Median (n; range) | 5 (99; 0–42) | 6 (52; 0–42) | 3 (38; 0–22) | 0.005 |
| NIHSS at discharge=0 | ||||
| % (n/n) | 24.5% (23/94) | 16.7% (8/48) | 36.8% (14/38) | 0.033 |
| mRS after 90 days; % (n/n) | ||||
| 0 | 24.0% (23/96) | 16.0% (8/50) | 40.5% (15/37) | 0.010 |
| 0–1 | 54.2% (52/96) | 48.0% (24/50) | 73.0% (27/37) | 0.019 |
| 0–2 | 62.5% (60/96) | 58.0% (29/50) | 78.4% (29/37) | 0.046 |
| 3–5 | 30.2% (29/96) | 36.0% (18/50) | 18.9% (7/37) | 0.082 |
| 6 | 7.3% (7/96) | 6.0% (3/50) | 2.7% (1/37) | 0.633 |
Significant p values are shown in bold.
mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; o-TICI, original Thrombolysis in Cerebral Infarction score.